ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 15

$340K Total Retail Price of All Prescriptions

Rank: 7 out of 15

415 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 415 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

6% of this provider’s 415 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,814 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $38 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
WARFARIN SODIUM 714 668 1 1
LEVOTHYROXINE SODIUM 356 348 2 3
FUROSEMIDE 317 293 3 4
LISINOPRIL 292 256 4 2
SIMVASTATIN 276 236 5 6
CITALOPRAM HBR 244 223 6 10
GABAPENTIN 239 204 7 12
METOPROLOL SUCCINATE 210 189 8 20
NAMENDA 187 187 9 19
MIRTAZAPINE 181 178 10 21
METOPROLOL TARTRATE 181 175 10 11
LANTUS 159 141 12 27
OMEPRAZOLE 148 142 13 7
ATORVASTATIN CALCIUM 129 124 14 18
AMLODIPINE BESYLATE 126 124 15 9
DONEPEZIL HCL 124 119 16 15
CARVEDILOL 121 116 17 31
POTASSIUM CHLORIDE 113 112 18 8
LIDODERM 102 99 19 52
CYMBALTA 102 98 19 38
POLYETHYLENE GLYCOL 3350 95 94 21 29
NOVOLOG 91 82 22 57
CARBIDOPA-LEVODOPA 91 91 22 32
PRAZOSIN HCL 83 83 24 102
METFORMIN HCL 81 75 25 16
LOSARTAN POTASSIUM 80 80 26 25
RANITIDINE HCL 76 71 27 22
SPIRONOLACTONE 76 64 27 37
ALENDRONATE SODIUM 75 75 29 46
QUETIAPINE FUMARATE 73 68 30 28
HYDROCODONE-ACETAMINOPHEN 69 66 S3 31 5
HYDROCHLOROTHIAZIDE 67 50 32 13
LOVASTATIN 61 59 33 40
ALLOPURINOL 59 56 34 36
RISPERIDONE 58 56 35 42
TRAZODONE HCL 57 53 36 14
OXYCODONE HCL 55 51 S2 37 24
SERTRALINE HCL 53 47 38 17
SEROQUEL 52 44 39 96
LACTULOSE 51 49 40 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.